This study will test a special powder for ulcers caused by a variety of conditions such as pressure that sometimes happen when a person is at the end of life. The powder will be applied to these ulcers to see if it helps with pain, odor and drainage (leakage). People who are being cared for by hospice or palliative care organizations will be invited to be in the study. The study will also find out if the powder is easy to use by caregivers as well as improving the comfort and quality of life of the person who has the ulcer.
Aim 1. In a comparative 2-group design, we will evaluate and compare the feasibility of the intervention through assessment in both settings (home-based and inpatient) on: 1. Adherence to RGN107 protocol by licensed care providers and/or family or other caregivers providing wound care; measures include implementation of procedures, frequency of dressing changes. 2. Reach, enrollment, disenrollment, acceptability, satisfaction; measures include difficulties with recruitment and enrollment, side effects such as burning, peri-wound skin irritation. 3. Usability issues such as powder ability to stick to wound and ease of use of applying powder. Aim 2. Estimate variability of outcome measurements and effect sizes and investigate the presence of a preliminary "signal" of clinical efficacy in two groups of hospice/home health/residential individuals receiving RGN107 in: 1. Physical wound symptoms outcomes, specifically pain, odor and exudate. 2. Quality of life of individuals receiving and caregivers using RGN107.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
50
Powder application to wound per protocol.
Roper Hospice
Charleston, South Carolina, United States
Hospice of Charleston
North Charleston, South Carolina, United States
Odyssey Hospice
North Charleston, South Carolina, United States
adherence
adherence to RGN107 protocol by licensed care providers and/or family or other caregivers providing wound care; measures include implementation of procedures, frequency of dressing changes.
Time frame: 4 weeks
reach
reach, enrollment, disenrollment, acceptability, satisfaction; measures include difficulties with recruitment and enrollment, side effects such as burning, peri-wound skin irritation.
Time frame: 4 weeks
usability
usability issues such as powder ability to stick to wound and ease of use of applying powder.
Time frame: 4 weeks
symptoms
physical wound symptoms outcomes, specifically pain, odor and exudate will be measured with visual analog scales
Time frame: 4 weeks
quality of life
quality of life of individuals receiving and caregivers using RGN107.
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.